echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The United States replaced Japan as the first market of Chinese medicine export

    The United States replaced Japan as the first market of Chinese medicine export

    • Last Update: 2018-02-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: China Journal of traditional Chinese medicine February 9, 2018 On February 6, the reporter learned from China Chamber of Commerce for the import and export of medical and health care products that according to the statistics of China Customs, in 2017, the export amount of traditional Chinese medicine was 3.64 billion US dollars, an increase of 2.07% year on year, the market of plant extracts was active, the export amount was 2.010 billion US dollars, an increase of 4.33% year on year, the export of traditional Chinese medicine was 250 million US dollars, an increase of 11.03% year on year, and the export of traditional Chinese medicine and decoction pieces continued to grow negatively, a decrease of 2% year on year .23% It shows that the export of traditional Chinese medicine is picking up In 2017, traditional Chinese medicine was exported to 118 countries and regions Asia is not only the traditional market of traditional Chinese medicine export, but also the main market In the first three quarters, the U.S market replaced Japan as the first market of Chinese medicine export According to the characteristics and historical classification of foreign trade, the main export forms of traditional Chinese medicine are proprietary Chinese medicine, traditional Chinese medicine, health products and extracts At present, the export of traditional Chinese medicine has gradually changed from traditional Chinese medicine to extract China's exports of traditional Chinese medicine to Japan and South Korea are mainly extracts and pieces of traditional Chinese medicine In addition to the export of ordinary extracts, they are mainly used as raw materials of Chinese medicine in Japan; the export of extracts to South Korea is mainly used as raw materials of health products and cosmetics As the largest extract Market in the United States, extract is mainly used in the production of dietary supplements and food additives, and the demand for raw materials has been relatively strong China's exports to Europe are mainly extracts, the main markets are Germany, Spain and France In foreign countries, Chinese patent medicines are still mainly consumed by Chinese communities, with limited growth in market capacity EU is the largest market of plant medicine in the world and one of the main target markets of Chinese patent medicine export In the first three quarters of 2017, China's exports of Chinese patent medicines to the original EU 15 countries reached US $5.053 million, an increase of 8.73% year on year The export volume of the 12 countries expanding to the east of the EU was US $2.3596 million, up 3.59% year on year In addition, according to statistics, in the first three quarters of 2017, the main varieties with large increase and decrease in the import and export trade of traditional Chinese medicine were as follows: the import volume of bird's nest was 48000 kg, up 84.89% year on year; the import volume of antler was 486000 kg, up 22.88% year on year, and 98.30% of the import volume came from New Zealand; the export volume of ginseng in China was 1178000 kg, down 18.36% year on year, mainly due to the Japanese and European markets Demand has weakened The reporter also learned that in recent years, the growth rate of the domestic economy slowed down, and the growth rate of the pharmaceutical industry decreased accordingly China's pharmaceutical industry has entered the era of structural optimization from the previous era of rapid expansion In this context, traditional Chinese medicine enterprises take the initiative to change, formulate international strategies, seek transformation and upgrading, and enter the international market is one of the upgrading paths for high-quality traditional Chinese medicine enterprises The number of Chinese medicine enterprises participating in international registration and certification is increasing, and the pace of registration in the mainstream pharmaceutical market is accelerating With the recognition of traditional Chinese medicine in Australia, Canada and other countries in the form of legislation, Chinese traditional medicine enterprises have successively registered products in Singapore, Cuba, Vietnam, the United Arab Emirates, Russia and other countries In addition, a group of traditional Chinese medicine enterprises represented by Shenwei, Lanzhou foci, Dior group, etc have actively applied for international high-end certification in recent years, hoping to obtain the priority to enter the mainstream pharmaceutical consumer market in Europe and the United States through certification, and have achieved initial results At the same time, in recent years, some Chinese medicine enterprises, which are at the front of internationalization, have begun to establish a marketing network in the global market by means of investment, merger and acquisition In 2013, TSL invested 1.82 million euros to acquire the Dutch Shenzhou pharmaceutical Center Co., Ltd under the Dutch hyderable Management Co., Ltd., and established the Dutch Shenzhou TSL Pharmaceutical Group Co., Ltd., which pioneered the overseas M & A in the field of traditional Chinese medicine Tongrentang Group has established a joint venture in the UK in the early 21st century, and has set up wholly-owned or joint-venture branches in Australia, South Korea, Singapore and other countries In November 2016, Tongrentang established an African Center in Johannesburg, South Africa through acquisition, and opened 5 stores in Johannesburg, Pretoria and Durban at the same time The vigorous growth of medical service trade also helps the "going out" of traditional Chinese medicine With the continuous extension and subdivision of the pharmaceutical industry chain, new business forms such as pharmaceutical R & D Contract outsourcing service, pharmaceutical production contract outsourcing service, pharmaceutical sales contract outsourcing service are gradually emerging, which is becoming a new form for Chinese traditional medicine enterprises to participate in the international division of labor Chinese medicine service speeds up the pace of "going out" Data shows that China sends about 2000 TCM clinicians every year, accounting for 60% of the total number of dispatched medical workers More than 60 TCM service trade institutions have opened TCM hospitals, TCM clinics, TCM health care institutions and TCM research centers in more than 20 countries and regions, with an annual reception of 250000 people In general, in 2017, the international market demand for pharmaceutical trade stabilized and recovered, the export volume steadily increased, China's pharmaceutical export structure further optimized, the pace of enterprise internationalization accelerated, new development momentum is forming, and the development situation of pharmaceutical trade is generally good.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.